Andrew D. Mitchell, MS

The Ohio State University

Poster(s):

• 1440 - Transcriptional reprogramming and survival co-dependencies of chronic lymphocytic leukemia resistant to venetoclax

• 1801 - Targeting BTKi-Resistant CLL Using the Dual Irreversible/Reversible 4th Generation BTK Inhibitor Rocbrutinib